Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2

Acta Biomaterialia

Volumn 4, Issue 5, 2008, Pages 1126-1138

  Patel, Zarana S ^a   Yamamoto, Masaya ^b   Ueda, Hiroki ^b   Tabata, Yasuhiko ^b   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Bone tissue engineering; Controlled release; Gelatin microparticles; Growth factor delivery

Indexed keywords

BONE; CELL ENGINEERING; GROWTH KINETICS; KINETICS; PROTEINS; SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; COMPOSITE SCAFFOLDS; CONTROLLED RELEASE; GELATIN MICROPARTICLES; GROWTH FACTOR DELIVERY; IN-VITRO; MICRO PARTICLES; RELEASE KINETICS;

CROSSLINKING;

BIOMATERIAL; BOLTON HUNTER REAGENT I 125; COLLAGENASE; GELATIN; GLUTARALDEHYDE; GROWTH FACTOR; PHOSPHATE BUFFERED SALINE; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TOSYLCHLORAMIDE SODIUM;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; COMPOSITE MATERIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; EQUILIBRIUM CONSTANT; FEMALE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION;

EID: 48649086321     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.04.002     Document Type: Article

References (45)

1. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H.P., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 41 (2007) 247
2. Burchardt H. The biology of bone graft repair. Clin Orthop (1983) 28
3. Kirker-Head C.A. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 43 (2000) 65
4. Lewis G. Alternative acrylic bone cement formulations for cemented arthroplasties: present status, key issues, and future prospects. J Biomed Mater Res B: Appl Biomater 84 (2008) 301
5. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 (2003) 873
6. Bostrom M.P. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop (1998) S116
7. Yamamoto M., Takahashi Y., and Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24 (2003) 4375
8. Kim B.S., and Mooney D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 16 (1998) 224
9. Whang K., Healy K.E., Elenz D.R., Nam E.K., Tsai D.C., Thomas C.H., et al. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 5 (1999) 35
10. Kellomaki M., Niiranen H., Puumanen K., Ashammakhi N., Waris T., and Tormala P. Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials 21 (2000) 2495
11. Wallkamm B., Schmid J., Hammerle C.H., Gogolewski S., and Lang N.P. Effect of bioresorbable fibres (Polyfibre) and a bioresorbable foam (Polyfoam) on new bone formation. A short term experimental study on the rabbit skull. Clin Oral Implants Res 14 (2003) 734
12. Cornell C.N., and Lane J.M. Current understanding of osteoconduction in bone regeneration. Clin Orthop (1998) S267
13. Duggirala S.S., Mehta R.C., and DeLuca P.P. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres. Pharm Dev Technol 1 (1996) 11
14. Schrier J.A., Fink B.F., Rodgers J.B., Vasconez H.C., and DeLuca P.P. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing. AAPS PharmSciTech 2 (2001) E18
15. Whang K., Tsai D.C., Nam E.K., Aitken M., Sprague S.M., Patel P.K., et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 42 (1998) 491
16. Saito N., Okada T., Horiuchi H., Murakami N., Takahashi J., Nawata M., et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 19 (2001) 332
17. Murakami N., Saito N., Takahashi J., Ota H., Horiuchi H., Nawata M., et al. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24 (2003) 2153
18. Geiger M., Li R.H., and Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55 (2003) 1613
19. Ueda H., Nakamura T., Yamamoto M., Nagata N., Fukuda S., Tabata Y., et al. Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor beta1. J Control Release 88 (2003) 55
20. Wang Y.J., Lin F.H., Sun J.S., Huang Y.C., Chueh S.C., and Hsu F.Y. Collagen-hydroxyapatite microspheres as carriers for bone morphogenic protein-4. Artif Organs 27 (2003) 162
21. Uludag H., Friess W., Williams D., Porter T., Timony G., D'Augusta D., et al. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann N Y Acad Sci 875 (1999) 369
22. Young S., Wong M., Tabata Y., and Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109 (2005) 256
23. Holland T.A., Tabata Y., and Mikos A.G. In vitro release of transforming growth factor-beta1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 91 (2003) 299
24. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101 (2005) 111
25. Tabata Y., Nagano A., and Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5 (1999) 127
26. Yamamoto M., Ikada Y., and Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12 (2001) 77
27. Isobe M., Yamazaki Y., Oida S., Ishihara K., Nakabayashi N., and Amagasa T. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J Biomed Mater Res 32 (1996) 433
28. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.H., Jansen J.A., and Mikos A.G. rhBMP-2 release from injectable poly(dl-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 85-A Suppl. 3 (2003) 75
29. Schrier J.A., and DeLuca P.P. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. Pharm Dev Technol 4 (1999) 611
30. Schrier J.A., and DeLuca P.P. Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release. AAPS PharmSciTech 2 (2001) E17
31. Hedberg E.L., Kroese-Deutman H.C., Shih C.K., Crowther R.S., Carney D.H., Mikos A.G., et al. In vivo degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds. Biomaterials 26 (2005) 4616
32. Fisher J.P., Vehof J.W., Dean D., van der Waerden J.P., Holland T.A., Mikos A.G., et al. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res 59 (2002) 547
33. Hedberg E.L., Kroese-Deutman H.C., Shih C.K., Crowther R.S., Carney D.H., Mikos A.G., et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J Biomed Mater Res A 72 (2005) 343
34. Wiemann M., Rumpf H.M., Bingmann D., and Jennissen H.P. The binding of rhBMP-2 to the receptors of viable MC3T3-E1 cells and the question of cooperativity. Materialwiss Werkstofftech 32 (2001) 931
35. Iwasaki S., Tsuruoka N., Hattori A., Sato M., Tsujimoto M., and Kohno M. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J Biol Chem 270 (1995) 5476
36. Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res, in press.
37. Haralson M.A., and Hassell J.R. Extracellular matrix: a practical approach (1995), IRL Press, Oxford
38. Greenwood F.C., Hunter W.M., and Glover J.S. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J 89 (1963) 14
39. Bolton A.E., and Hunter W.M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J 133 (1973) 29
40. Shung A.K., Behravesh E., Jo S., and Mikos A.G. Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. Tissue Eng 9 (2003) 243
41. Porter B.D., Oldham J.B., He S.L., Zobitz M.E., Payne R.G., An K.N., et al. Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng 122 (2000) 286
42. Patel Z.S. Controlled delivery of angiogenic and osteogenic growth factors for bone regeneration (2008), Rice University, Houston, TX
43. Holland T.A., Tessmar J.K., Tabata Y., and Mikos A.G. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 94 (2004) 101
44. Ikada Y., and Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31 (1998) 287
45. Parks W.C. Matrix metalloproteinases in repair. Wound Repair Regen 7 (1999) 423